Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Pharmacother ; 103: 1028-1034, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29710660

RESUMO

Taurine, an amino acid with antioxidant and osmoregulatory properties, has been studied for its possible antidiabetic properties in type 1 and type 2 diabetic animals. In type 2 diabetic mice, taurine decreases blood glucose through increased insulin secretion and insulin receptor sensitization. However, insulin is absent in type 1 diabetic individuals. The aim of this study was to evaluate the effects of taurine on parameters related to the energy balance that could explain the metabolic action of this amino acid in type 1 diabetic rats. Control and streptozotocin-induced diabetic rats received saline or taurine (100 mg/kg/day), intraperitoneally, for 30 days. Parameters such as palatable food intake, gastrointestinal transit rate, serum glucose, insulin, leptin, and glucagon levels were measured 60 min after the last taurine administration. Liver, kidneys, heart, and retroperitoneal fat were dissected and weighted. Glycogen levels were measured in the liver and soleus muscle. Our results showed that acute taurine administration decreased glycemia. It also decreased food intake in diabetic rats, without affecting other metabolic parameters. Altogether, our results suggest that in type 1 diabetic rats, taurine decreases blood glucose by a non-insulin-dependent mechanism. Due to the safety profile of taurine, and its effect on glycemia, this amino acid may help to design new drugs to add benefit to insulin therapy in type 1 diabetic individuals.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 1/tratamento farmacológico , Ingestão de Alimentos/efeitos dos fármacos , Hipoglicemiantes/farmacologia , Taurina/farmacologia , Animais , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Hipoglicemiantes/administração & dosagem , Hipoglicemiantes/uso terapêutico , Injeções Intraperitoneais , Masculino , Ratos Wistar , Estreptozocina , Taurina/administração & dosagem , Taurina/uso terapêutico
2.
Amino Acids ; 50(1): 95-104, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28936709

RESUMO

Diabetes is a chronic metabolic disease associated with oxidative stress, damage to biomolecules such as DNA, and neuroinflammation. Taurine, a sulfur-containing amino acid widespread in the brain, has neuroprotective properties that might prevent tissue injury and DNA damage induced by chronic hyperglycemia. We evaluated the effects of chronic taurine treatment on oxidative stress parameters, DNA damage and inflammatory markers in the frontal cortex, and hippocampus of streptozotocin-induced diabetic rats. Diabetic rats displayed increased levels of reactive oxygen species (ROS) and DNA damage in both areas, evidencing the pro-oxidant effects of diabetes in the brain. Moreover, this condition increased levels of several inflammatory mediators, such as IL-6, IL-12, TNF-γ, and IFN-α, more pronouncedly in the hippocampus. Supporting our hypothesis, taurine treatment reduced ROS, DNA damage, and inflammatory cytokine levels, providing evidence of its beneficial effects against genotoxicity and neuroinflammation associated with diabetes. Our data endorse the necessary clinical trials to evaluate the efficacy and safety of taurine supplementation in the prevention and treatment of neurochemical and metabolic alterations related to diabetes.


Assuntos
Encéfalo/efeitos dos fármacos , Diabetes Mellitus Experimental/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Taurina/farmacologia , Animais , Antioxidantes/metabolismo , Encéfalo/metabolismo , Encéfalo/patologia , Citocinas/análise , Dano ao DNA/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Masculino , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo , Taurina/uso terapêutico
3.
Cad Saude Publica ; 30(10): 2049-56, 2014 Oct.
Artigo em Português | MEDLINE | ID: mdl-25388308

RESUMO

Coping skills correlate directly with the success of alcohol abstinence. Brazil previously lacked an instrument to identify alcohol users' specific coping skills. The current study therefore aimed to perform the translation, cross-cultural adaptation, and content validation of the Coping Behaviours Inventory (CBI). Procedures included translation and back-translation, cross-cultural adaptation, content evaluation, and a pilot study. The final Portuguese version was administered by telephone to 40 alcohol users seeking help through a telephone hotline called VIVAVOZ. The retranslated version was close to the original. As for content validation, most of the items proved satisfactory and acceptable. The theoretical dimension showed a mean kappa index of 0.666 between evaluators, which was considered a substantial level of agreement. The results were satisfactory and acceptable, demonstrating that the inventory is appropriate for investigating coping skills in Brazilian alcohol users.


Assuntos
Adaptação Psicológica , Alcoolismo/psicologia , Inquéritos e Questionários , Traduções , Brasil , Características Culturais , Humanos , Projetos Piloto , Reprodutibilidade dos Testes , Autoavaliação (Psicologia)
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...